Maria Adelaida García-Gimeno

Affiliations: 
Universidad Politécnica de Valencia 
Google:
"Maria García-Gimeno"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Moreno-Estellés M, Campos-Rodríguez Á, Rubio-Villena C, et al. (2023) Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model. International Journal of Molecular Sciences. 24
Vela M, García-Gimeno MA, Sanchis A, et al. (2021) Neuroprotective Effect of IND1316, an Indole-Based AMPK Activator, in Animal Models of Huntington Disease. Acs Chemical Neuroscience
Brewer MK, Machio-Castello M, Viana R, et al. (2021) An empirical pipeline for personalized diagnosis of Lafora disease mutations. Iscience. 24: 103276
Kumarasinghe L, Xiong L, Garcia-Gimeno MA, et al. (2021) TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases. Cells. 10
Perez-Jimenez E, Viana R, Muñoz-Ballester C, et al. (2020) Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease. Glia
Sanz P, Garcia-Gimeno MA. (2020) Reactive Glia Inflammatory Signaling Pathways and Epilepsy. International Journal of Molecular Sciences. 21
Espinós C, Galindo MI, García-Gimeno MA, et al. (2020) Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration. Antioxidants (Basel, Switzerland). 9
Sanchis A, García-Gimeno MA, Cañada-Martínez AJ, et al. (2019) Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease. Experimental & Molecular Medicine. 51: 65
García-Gimeno MA, Knecht E, Sanz P. (2018) Lafora Disease: A Ubiquitination-Related Pathology. Cells. 7
Garcia-Gimeno MA, Rodilla-Ramirez PN, Viana R, et al. (2018) A novel EPM2A mutation yields a slow progression form of Lafora disease. Epilepsy Research. 145: 169-177
See more...